ImmunityBio, Inc. (IBRX)
8.22
-0.09
(-1.08%)
USD |
NASDAQ |
Oct 23, 16:00
8.22
0.00 (0.00%)
Pre-Market: 20:00
ImmunityBio Market Cap : 8.657B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 8.657B |
| October 22, 2026 | 8.752B |
| October 21, 2026 | 9.100B |
| October 20, 2026 | 9.237B |
| October 19, 2026 | 8.868B |
| October 16, 2026 | 9.669B |
| October 15, 2026 | 10.53B |
| October 14, 2026 | 10.44B |
| October 13, 2026 | 10.32B |
| October 12, 2026 | 10.66B |
| October 09, 2026 | 11.07B |
| October 08, 2026 | 10.44B |
| October 07, 2026 | 10.27B |
| October 06, 2026 | 10.21B |
| October 05, 2026 | 10.93B |
| October 02, 2026 | 10.83B |
| October 01, 2026 | 9.774B |
| September 30, 2026 | 9.942B |
| September 29, 2026 | 9.300B |
| September 28, 2026 | 8.973B |
| September 25, 2026 | 8.889B |
| September 24, 2026 | 9.100B |
| September 23, 2026 | 9.089B |
| September 22, 2026 | 9.784B |
| September 21, 2026 | 8.900B |
| Date | Value |
|---|---|
| September 18, 2026 | 8.931B |
| September 17, 2026 | 8.910B |
| September 16, 2026 | 8.331B |
| September 15, 2026 | 8.573B |
| September 14, 2026 | 8.815B |
| September 11, 2026 | 8.331B |
| September 10, 2026 | 8.131B |
| September 09, 2026 | 8.489B |
| September 08, 2026 | 8.731B |
| September 04, 2026 | 8.510B |
| September 03, 2026 | 8.626B |
| September 02, 2026 | 8.373B |
| September 01, 2026 | 8.289B |
| August 31, 2026 | 8.373B |
| August 28, 2026 | 8.478B |
| August 27, 2026 | 8.847B |
| August 26, 2026 | 8.689B |
| August 25, 2026 | 8.626B |
| August 24, 2026 | 7.983B |
| August 21, 2026 | 8.205B |
| August 20, 2026 | 8.257B |
| August 19, 2026 | 8.563B |
| August 18, 2026 | 8.131B |
| August 17, 2026 | 8.342B |
| August 14, 2026 | 7.973B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Moderna, Inc. | 79.84B |
| Sarepta Therapeutics, Inc. | 1.873B |
| Arrowhead Pharmaceuticals, Inc. | 8.189B |
| Oncolytics Biotech, Inc. | 62.61M |
| Sangamo Therapeutics, Inc. | 47.64M |
Market Cap Related Metrics
| PS Ratio | 49.74 |
| PEG Ratio | -0.0878 |
| Price | 8.22 |
| Earnings Yield | -11.79% |
| PEGY Ratio | -0.0878 |